Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $37.7300 (-1.41%) ($37.2400 - $39.0500) on Wed. Nov. 11, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3% (three month average) | RSI | 71 | Latest Price | $37.7300(-1.41%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2.7% a day on average for past five trading days. | Weekly Trend | HALO advances 11.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from value to growth for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(48%) IWM(47%) IWC(44%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.5% in a week (0% probabilities). VIXM(-31%) UUP(-14%) VXX(-13%) EDOC(-6%) TLT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.5% (StdDev 3%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $36.79(2.56%) | 10 Day Moving Average | $33.61(12.26%) | 20 Day Moving Average | $31.79(18.69%) | To recent high | -1.4% | To recent low | 46.6% | Market Cap | $5.157b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |